Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Conditions: Breast Neoplasms; Breast Cancer Intervention: Behavioral: PACHA Program Sponsors: CHU de Quebec-Universite Laval; Canadian Institutes of Health Research (CIHR); Fondation Cancer du Sein du Québec Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence
Conditions: Insomnia; Breast Cancer; Adherence, Medication; Quality of Life; Survivorship Intervention: Behavioral: Cognitive behavioural therapy for insomnia Sponsor: University of Strathclyde Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Conditions: Breast Neoplasms; Breast Cancer Intervention: Behavioral: PACHA Program Sponsors: CHU de Quebec-Universite Laval; Canadian Institutes of Health Research (CIHR); Fondation Cancer du Sein du Québec Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence
Conditions: Insomnia; Breast Cancer; Adherence, Medication; Quality of Life; Survivorship Intervention: Behavioral: Cognitive behavioural therapy for insomnia Sponsor: University of Strathclyde Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Conditions: Breast Neoplasms; Breast Cancer Intervention: Behavioral: PACHA Program Sponsors: CHU de Quebec-Universite Laval; Canadian Institutes of Health Research (CIHR); Fondation Cancer du Sein du Québec Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence
Conditions: Insomnia; Breast Cancer; Adherence, Medication; Quality of Life; Survivorship Intervention: Behavioral: Cognitive behavioural therapy for insomnia Sponsor: University of Strathclyde Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Conditions: Breast Neoplasms; Breast Cancer Intervention: Behavioral: PACHA Program Sponsors: CHU de Quebec-Universite Laval; Canadian Institutes of Health Research (CIHR); Fondation Cancer du Sein du Québec Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Impact of Cognitive Behavioural Therapy for Insomnia on Endocrine Therapy Adherence
Conditions: Insomnia; Breast Cancer; Adherence, Medication; Quality of Life; Survivorship Intervention: Behavioral: Cognitive behavioural therapy for insomnia Sponsor: University of Strathclyde Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Pilot Study of PACHA Program to Enhance Adherence to Adjuvant Endocrine Therapy Among Breast Cancer Survivors
Conditions: Breast Neoplasms; Breast Cancer Intervention: Behavioral: PACHA Program Sponsors: CHU de Quebec-Universite Laval; Canadian Institutes of Health Research (CIHR); Fondation Cancer du Sein du Québec Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2023 Category: Research Source Type: clinical trials
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Condition: Breast Cancer Interventions: Drug: Ovarian Function Suppression + Aromatase Inhibitor; Drug: Adjuvant Chemotherapy + Ovarian Function Suppression Sponsors: NRG Oncology; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 30, 2023 Category: Research Source Type: clinical trials
